Table 2.

Treatment Characteristics Overall and by Disease Type

Characteristic	All Patients (N = 83)	HCC (n = 44)	ICC (n = 39)
	% (No.) or Median (range)	% (No.) or Median (range)	% (No.) or Median (range)
Gross tumor volume, mL*	127.2 (3.7-2,045.0)	106.4 (4.4-2,045.0)	133.7 (3.7-599.7)
Whole liver volume, mL	1,600.1 (612.9-3,369.3)	1,744.0 (895.0-3,369.3)	1,487.0 (612.9-2,522.4)
Mean liver dose, GyRBE	19.2 (3.2-29.5)	18.4 (6.2-29.3)	21.4 (3.2-29.5)
Dose delivered, GyRBE	58.0 (15.1-67.5)	58.0 (40.5-67.5)	58.0 (15.1-67.5)
Dose completed	94.0% (78)	95.5% (42)	92.3% (36)

Abbreviations: GyRBE, Gy × relative biologic effectiveness.

^*n = 82.